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Fine needle sampling is a fast, safe, and potentially cost-eﬀective method of obtaining tissue for cytomorphologic assessment
aimed at both initial triage and, in some cases, complete diagnosis of patients that present clinically with lymphadenopathy. The
cytologic diagnosis of B-cell non-Hodgkin lymphomas composed of small-/intermediate-sized cells, however, has been seen as
an area of great diﬃculty even for experienced observers due to the morphologic overlap between lymphoma and reactive lym-
phadenopathiesaswellasbetweenthelymphomaentitiesthemselves.Althoughancillarytestinghasimproveddiagnosticaccuracy,
the results from these tests must be interpreted within the morphological and clinical context to avoid misinterpretation. Impor-
tantly, the recognition of speciﬁc cytologic features is crucial in guiding the appropriate selection of ancillary tests which will either
conﬁrm or refute a tentative diagnosis. For these reasons, we here review the cytologic characteristics particular to ﬁve common B-
cellnon-Hodgkinlymphomaswhichtypicallycausethemostdiagnosticconfusionbasedoncytologicalassessmentalone:marginal
zone lymphoma, follicular lymphoma, mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, and
lymphoplasmacytic lymphoma. We summarize the most pertinent cytomorphologic features for each entity as well as for reactive
lymphoid hyperplasia, contrast them with each other to facilitate their recognition, and highlight common diagnostic pitfalls.
1.Introduction
Over the past 25 years, a large number of articles have been
published and signiﬁcant academic discourse has occurred,
and continues to occur, around the usefulness and role of
cytopathology in the diagnosis of lymphoma [1–3]. Sophis-
ticated ancillary techniques have changed the landscape
considerably and now play a major role in the diagnosis
of lymphoproliferative disorders. We decided therefore to
revisitthecytologicdiagnosisoftheﬁvemostcommonB-cell
non-Hodgkin lymphomas (NHL) with small-/intermediate-
sized cells with a renewed focus on morphology itself. In the
followingarticle,wewillfocusoncytologicsamplesobtained
from lymph nodes by the use of small caliber needles, that
is, ﬁne-needle sampling/aspiration. We will not discuss the
speciﬁcs of other specimen types such as samples of body
cavity eﬀusions or cerebrospinal ﬂuid.
The primary and most signiﬁcant role of ﬁne-needle
sampling in undiagnosed lymphadenopathy is to triage the
patient appropriately for further management which may
include subsequent diagnostic procedures such as excisional
or core biopsy. Broadly, ﬁne needle specimens can be cate-
gorized into neoplastic and nonneoplastic. Among the non-
neoplastic specimens, the possible diagnoses include normal
lymphoid tissue, nonspeciﬁc reactive change, inﬂammatory
changesindicativeofaspeciﬁcprocesssuchassuppurativeor
granulomatous lymphadenitis, or rarely lymphadenopathies
of unknown etiology such as Rosai-Dorfman disease. Within
the neoplastic category, the most important distinction
to be made is between primary lymphoid and secondary
metastaticneoplasms.Subsequentconsiderationsincludethe
type and, if possible, the grade of the neoplasm in order to
assign the patient to the most appropriate path for further
management.Inpatientswithapriordiagnosisoflymphoma
additional questions arise such as the potential presence of
changes related to therapy, the assessment for transforma-
tion/progression from a low-grade lymphoma to a higher
grade, the recurrence of previously treated lymphoma, and2 Pathology Research International
theexclusionorinclusionofasynchronousormetachronous
second malignancy.
The principle advantage of ﬁne-needle sampling, parti-
cularly in superﬁcial palpable lymph nodes, is the ease of
specimen acquisition, which provides rapid access to diag-
nostic material not requiring the extensive tissue processing
associated with excisional biopsies. Fine needle sampling
causesonlyminimalpatientdiscomfortandhasthepotential
to spare at least a proportion of patients from a surgical pro-
cedure if subsequent lymphadenectomy is deemed unneces-
sary. When small caliber needles are used (25 gauge or 27
gauge), the risk of subsequent histology being compromised
in any way by infarction, hematoma, or other artifact is very
small. In selected patients with a single accessible enlarged
lymph node and with an established diagnosis of lymphoma,
the node can be spared from excision for later clinical
assessment of a therapeutic response. In patients with multi-
focal disease multiple ﬁne-needle samples permit the map-
ping of sites of involvement and planning of the optimal
site for excisional biopsy where required. Also, ﬁne-needle
sampling maybe the most practical way to assess patients
with deep seated lymphadenopathy or those who are too ill
toundergomoreinvasiveprocedures[4,5].Disadvantagesof
ﬁne-needle sampling of lymph nodes are mainly associated
with the nature of the specimen in which architectural
features, although not completely absent, are less obvious
than in histologic preparations. There is a known potential
for sampling error and bias which may be alleviated to some
degree by using multiple needle passes into a single lymph
node, ultrasound guidance to ensure sampling of diﬀerent
areas of a node, and sampling of multiple lesions in patients
that present with more than a single enlarged lymph node.
Concurrent core needle biopsy or ﬁne-needle sampling with
on-site evaluation and possible conversion to core biopsy
havebothbeenadvocatedtoimprovespecimenadequacy[5–
7].Interestingly,Gongetal.concludedthattherewasnoclear
advantage in the diagnosis and classiﬁcation of small B-cell
NHL by adding core needle biopsy to ﬁne-needle sampling
[6].
Opponentsmayarguethatﬁne-needlesamplingprovides
only limited material for ancillary testing. Lymphoid tissues
are, however, predisposed to a rich cellular harvest due to a
lack in cellular cohesion. Even in the case of a paucicellular
specimen, appropriate sample processing will permit sub-
sequent studies with minimal amounts of material. Finally,
the technique of ﬁne-needle sampling itself requires a certain
amount of training: failure to render a speciﬁc cytologic
diagnosis is frequently associated with a lack of recognition
thatthecomponentstepsofsampleacquisitionandhandling
are simple, but not trivial.
2. PrerequisitesandTechniques for
Lymph Node Cytology
Diﬃculties associated with the diagnosis of B-cell NHL with
small-/intermediate-sized cells by cytomorphology alone are
mostly related to the morphologic overlap between the
entities as well as with the changes that occur normally
in benign, reactive lymph nodes [8, 9]. Some cases may
display partial involvement of a lymph node by a neoplastic
process, adding to the diagnostic challenge. Familiarity with
the spectrum of “normal” changes in a lymph node, and
the morphologic ﬁndings associated with them is essential.
Lymph node morphology may also vary with respect to the
bodysiteasexempliﬁedbyanincreasednumberofsecondary
follicles in cervical lymph nodes, the increased occurrence
of plasma cells, monocytes, macrophages and mast cells in
deep/mesenteric nodes, and the presence of pigment and/or
benign cellular inclusions in lymph nodes from body sites
such as the mediastinum or axillary region.
The background of a smear produced from a cytologic
specimen of a lymph node usually shows an abundance of
S¨ oderstrom bodies, mostly referred to as lymphoglandular
bodies (LGB), which measure 2–10 micrometers in size and
occur both in benign and malignant lymph node aspirates
[10]. These structures may be fragments of fragile lymphoid
cellcytoplasmavulsedfromcellsduringsampling.Occasion-
ally though, LGBs are found within the cytoplasm of histio-
cyteswhichmayindicatetheirexistenceinvivo.Thepr esenc e
or absence of LGBs is not entirely speciﬁc for a lymphoid
proliferation since occasional lymph node aspirates may dis-
playapaucityofthesestructureswhereassamplesfromsome
nonlymphoid tumors can have frequent, easily identiﬁable
cytoplasmic fragments [11]. In general, the presence of LGBs
in an aspirate, especially if there are more than 20 per high
power ﬁeld, indicates sampling of a lymphoid organ such
as lymph node, spleen, thymus, tonsil, or of an extranodal
lymphoidproliferation[12,13].ThenumberofLGBsmaybe
conspicuously increased if a lymphoid neoplasm is present.
Fine-needle sampling performed with a needle as thin as
2 7g a u g el e a v e sc o m p o n e n t so ft h el y m p hn o d ea r c h i t e c t u r e
intact and, if conventional smears rather than liquid-based
cytology are used, these structures will be present on the
slide. The most commonly observed part of the native
lymph node architecture present in cytological preparations
is the lymphohistiocytic aggregate (LHA) or germinal center
fragment. LHAs are characterized by the presence of cells
of the mononuclear phagocyte system, especially tingible
body macrophages (TBMs), which are frequently observed
in benign, reactive, or “follicular” lymphoid hyperplasia.
Like the secondary follicles of follicular hyperplasia, LHAs
are quite variable in size and may be dominated by
activated cells (centroblasts) associated with the germinal
center reaction. A follicle center fragment (FCF), on the
contrary, is an aggregate of lymphoid cells arranged around
a meshwork of follicular dendritic cells (“kissing cells”) the
interdigitating cytoplasm of which can be highlighted by
immunohistochemical staining for CD21 and/or CD23. The
latter type of cell aggregate, by some authors referred to as
pseudo-LHA [12], may also occur in benign samples, but is
seen in increased frequency in smears prepared from lymph
nodes involved by follicular lymphoma (FL), constituting an
important diagnostic clue in this particular setting. Notably,
FCFs in FL are often small and similar in size imparting
an “architectural” monomorphism which can be recognized,
often grossly, in smear preparations [14]. FCFs may be mim-
icked in smears occasionally by other cell aggregates suchPathology Research International 3
Figure 1: Historical depiction of diﬀerent lymphoid cell types.
Schleip examined the heterogeneity of lymphoid cells in peripheral
blood ﬁlms. This image taken from the atlas published based on
his observations illustrates the variable nuclear morphology and
cytoplasmic content of benign lymphoid cells in diﬀerent states of
activation.
as the densely packed groups of cells associated with prolif-
eration centers, or pseudofollicles, seen in chronic lympho-
cytic leukemia/small lymphocytic lymphoma (CLL/SLL). In
CLL/SLL, no follicular dendritic cells should be visible, but
prolymphocytesandparaimmunoblastswillbepresent.Also,
it is important to note that occasional “true” FCFs can be
found in mantle cell lymphoma (MCL) and marginal zone
lymphoma (MZL), and that LHAs can be seen whenever
benign lymphoid tissue is sampled at the same time as
lymphoma. Other, less frequently observed cell aggregates in
smear preparations may consist of capillary-size vessels with
attached lymphoid tissue or occasional aggregates of adipose
tissue inﬁltrated by lymphoid cells.
Readily recognizable normal lymphoid constituents seen
in ﬁne-needle samples from benign/reactive lymph nodes
include small round lymphocytes (either functionally
“na¨ ıve” or terminally diﬀerentiated memory cells or unstim-
ulated T-cells), centrocytes, centroblasts, immunoblasts, and
plasma cells. Common nonlymphoid cell types present in
the aspirate are follicular and interdigitating dendritic cells
located mainly in germinal centers and paracortex, respec-
tively. Constituents such as histiocytes, macrophages, plas-
macytoid monocytes, and epithelioid cells are related to the
m o n o n u c l e a r - p h a g o c y t es y s t e m .O t h e rc e l lt y p e sa r em a s t
cells, basophils, neutrophils, eosinophils, endothelial cells,
and occasional fat cells. Small lymphocytes have an approx-
imate size of 6–12 micrometers, comparable to a histiocyte
nucleus. Practically, erythrocytes and neutrophils are more
convenient comparators. The small lymphocyte is usually
about twice the size of an erythrocyte and somewhat smaller
than the nucleus of a segmented neutrophil. Mature, circu-
lating lymphocytes dominate at the lower end of this size
spectrum and activated lymphocytes at the upper end. Large
lymphocytesmayexceed20micrometersize,equivalenttoor
greater than the diameter of 3 erythrocytes, and larger than
a histiocyte or neutrophil nucleus. Lymphocytes that fulﬁll
neither size criterion, usually designated as “intermediate,”
include many centrocytes and some centroblasts. It is not
unusual for a “small” B-cell lymphoma to be composed
mainly of cells that fall into this intermediate size range.
Thisbroadspectrumoflymphocytesizeandmorphologyhas
been long recognized and documented (Figure 1)[ 15].
The character of the nuclear chromatin, the presence
or absence and size of nucleoli, and the character of the
cytoplasm (including cytoplasmic granulations) provide
bettercluestotheidentiﬁcationofthepositionofalymphoid
cell within the functional spectrum than size alone. The
typical cytologic features of small round lymphocytes are a
regular nuclear contour, dense chromatin, invisible nucleoli,
and a narrow rim of cytoplasm. Cells with these properties
in medullary cords and sinuses are mainly B cells, but in the
paracortex of the lymph node will mainly consist of T-cells.
Some small round T-lymphocytes are also present within the
germinal centers. The na¨ ıve cells of the primary follicle and
the mantle zone are very similar but display a slightly more
irregular nuclear contour and slightly more open chromatin.
B-cells of the marginal zone are characterized by slightly
irregular nuclear contours and moderate amounts of pale
cytoplasm. Cell types of the lymphoid lineage recognizable
in ﬁne-needle specimens include centrocytes, centroblasts,
prolymphocytes/(para-)immunoblasts, plasmablasts, plas-
macytoid lymphocytes, plasma cells, and monocytoid lym-
phocytes. Overlap between these cell types occurs, so that it
may be diﬃcult to deﬁnitively classify some individual cells
based on cytomorphology alone. Overall, the small round
lymphocyteisalwaysthemostfrequentcellinreactivelymph
nodes. However, the predominance or increased occurrence
of any of these cell types, including the small round lymph-
ocyte, should lead at least to the consideration of a neoplastic
p r o c e s sa sp a r to ft h ed i ﬀerential diagnosis.
The success of ﬁne-needle cytology is dependent on
samples of high cellularity and excellent technical prepara-
tion.Severalarticlesandtextbookshavedetaileddescriptions
of the technique of ﬁne-needle sampling with aspiration
[16]. Brieﬂy, ﬁne-needle sampling of superﬁcial nodes with
suction is performed using a 23–27 gauge needle ﬁtted to
a 10mL syringe which may be attached to a one hand
grip syringe holder for convenience. Larger needles should
be avoided since they will cause considerable admixture of
the sample with peripheral blood. Local anesthesia is rarely
required for the sampling of superﬁcial, palpable lesions
which should be almost painless. Local anesthesia, however,
is used in cases where penetration of pleura or peritoneum is
necessary. The sampling of a superﬁcial lesion is performed
with the mass immobilized between two ﬁngers while one
or two needle passes consisting of several (5–10) strokes
each are performed. At this stage, the sampling is for the
most part due to detachment of cells and tissue fragments
by the cutting edge of the needle as described in the method
published by Zajdela et al. [17] whereas excessive aspiration
may increase the blood content of the sample. The material
obtained in this way is often suﬃc i e n tf o rs e v e r a ls m e a r sa n d
a cell suspension for ancillary studies. Nonpalpable lesions
are sampled with the aid of imaging modalities such as
ultrasonography or computer tomography.
The obtained sample is then placed on a glass slide and a
“splitting” or “touch-oﬀ technique” can be used to generate
several matching smears from the same sample (Figure 2).
After the sample is expelled onto the slide, the smear is
produced by even and thin spreading of the cells with a sec-
ond“spreader”slideusingtheso-called“one-step”technique4 Pathology Research International
Figure 2: Hand position during the one-step smear with touch-oﬀ
which allows multiple smears to be produced from a single ﬁne-
needle sample. The sample is expelled from the needle and placed
near the frosted end of the “receiver” slide (1). The “spreader” slide
(2) is then lowered in a hinge-like fashion onto the receiver slide
from above, allowing the sample to disperse by capillary action,
and then drawn down the length of the receiver slide producing the
characteristic“bulletshapewithfeatheredge.”Ifusingthetouch-oﬀ
technique, the spreader slide is lowered to pick up a small amount
of the specimen and then turned over so that a clean glass surface
can be used to spread the remaining sample on the receiver slide.
The picked up sample on the reverse of the spreader slide (arrow) is
then used to generate a second smear.
[18]. During this step, it is important not to apply too much
pressure which will destroy fragile cells. Ideally direct smears
are subsequently processed using both Papanicolaou and
Romanowsky-type stains on paired slides after alcohol ﬁx-
ation and air-drying, respectively. The two staining methods
highlightdistinctcellularfeaturestherebyproducingcompli-
mentary diagnostic information. In general, alcohol ﬁxation
with Papanicolaou stain emphasizes nuclear detail whereas
air-drying with Romanowsky-type stains demonstrates the
cytoplasm more eﬀectively. Also, Romanowsky-type stains
diﬀerentially color DNA a metachromatic purple and RNA
blue. Diﬀ-Quik, a proprietary “quick” stain, or other non-
proprietary modiﬁed staining methods are frequently used
and are particularly suitable for immediate specimen assess-
mentinsituationswhereconﬁrmationofspecimenadequacy
is crucial [19]. It should be noted, though, that the higher
concentration of methylene blue present in Diﬀ-Quik and
similar rapid stains can sometimes cause ﬁne blastic chro-
matin to appear darker and more mature than it otherwise
would, and produce the appearance of “pseudonucleoli” in
cells if staining is performed on an incompletely dried smear.
May-Gr¨ unwald-Giemsa (MGG) stain provides more subtle
coloration of nuclei and is superior for staining of cytoplas-
mic granulations. MGG is highly pH-dependent and may be
diﬃculttostandardize.Finally,cellsuspensionsareproduced
by aspiration of sterile physiological saline, phosphate-
buﬀered saline solution, or cell culture medium from a
tube through the sampling needle into the syringe. The cell
suspension can then be used for ancillary testing purposes
and either directly submitted for ﬂow or slide-based cytom-
etry or, after further processing as cytospin preparation or
cell block, for immunocytochemistry or ﬂuorescence in-situ
hybridization (FISH). Cell suspensions are ideal material for
more specialized molecular methods that may be required
for diagnostic and research purposes including polymerase-
chain reaction (PCR) and gene expression proﬁling. Very
small amounts of residual cell suspension can be expelled
onto an FTA card or paper for indeﬁnite storage of DNA.
3. DifferentialDiagnosisof B-Cell NHLs
Composed of Small-/Intermediate-SizeCells
A sequential approach to the examination of ﬁne-needle
samples from lymph nodes includes the initial assessment of
cellularity and adequacy of the sample. As with samples from
other sites, an absolute deﬁnition of adequacy is diﬃcult.
Pambuccian and Bardales propose a minimum number of
40 lymphoid cells per high power ﬁeld in the area of highest
cellularity as criterion to consider an aspirate as adequate
in cases not showing granulomas or metastatic malignancy
[12]. By this deﬁnition, an extensively hemodiluted spec-
imen would be considered inadequate for the purpose of
establishing a complete diagnosis, although it still might
yield useful information. Other adequacy criteria related to
the quality of the cytologic preparation include a uniform,
thin smear resulting in a “bullet shape with feather edge”
appearance, lack of involvement of the slide margins, and
absence of extensive artifacts [12]. The slide should be
examined grossly to determine if the cells smeared diﬀusely
or focally form small or large aggregates. Next, there should
be an assessment of the slide background which, in the case
ofreactivelymphnodesorsmallB-cellNHLs,shouldcontain
numerous LGBs without presence of extraneous elements.
Depending on the anatomic site sampled, however, a variety
of noncellular material may be present such as anthracotic
pigment in mediastinal nodes sampled by endobronchial
ultrasound with transbronchial needle aspiration or melanin
pigment in axillary lymph nodes involved by dermatopathic
lymphadenopathy.Thesubsequentstepsincludealowpower
assessment of the lymphoid cell population for its (a)
composition (mono-/dimorphic versus polymorphic), (b)
presence, density, and nature of cell aggregates (FCF versus
LHA), and (c) any cell predominance or presence of atypical
cells (small versus intermediate versus large cells). The ﬁnal
step is the assessment of the sample at high power during
which the speciﬁc nature of the lymphoid population is
elicited through recording of the cytologic features of any
predominantcellpopulationwithorwithoutadmixedminor
cellular component(s).
In the following section, we will review the cytologic fea-
tures of B-cell lymphomas characterized by a predominance
of cells with small to intermediate size and consider possible
diagnostic pitfalls. In the context of the most pertinent
clinical scenarios, we will discuss areas of morphologic
overlap and important diﬀerential diagnoses.
3.1. Reactive Lymphoid Hyperplasia. Reactive lymphoid
hyperplasia (RLH) is the most common cause for a poly-
morphic lymphoid cell pattern in a ﬁne-needle sample andPathology Research International 5
(a) (b) (c)
(d) (e) (f)
Figure 3: Smears produced from lymph node ﬁne-needle samples and examined at low power. Low power assessment shows the
diﬀerences in cell composition and the presence or absence of cell aggregates in reactive lymphoid hyperplasia (a), marginal zone
lymphoma (b), follicular lymphoma (c), mantle cell lymphoma (d), chronic lymphocytic leukemia/small lymphocytic lymphoma (e), and
lymphoplasmacytic lymphoma (f). Note the variable size and frequency of aggregates in reactive lymphoid hyperplasia (black arrowheads).
Compare with the monomorphism of the small aggregates in follicular lymphoma (white arrowheads) and the absence or vague delineation
of aggregates in the other lymphoma cases. Also, there is a markedly more polymorphic cell composition in reactive lymphoid hyperplasia
as compared to the other cases. (d: Diﬀ-Quik, all other: May-Gr¨ unwald-Giemsa; 10x).
is mostly associated with benign, reactive and reversible
lymphadenopathy. The histologic correlate is an expansion
of the sinusoidal, follicular, paracortical, or medullary area
of a lymph node leading to corresponding changes in cellu-
lar composition. Two distinct patterns of RLH exist with (a)
follicular hyperplasia as correlate of a B-cell response and
(b) paracortical hyperplasia as correlate of a T-cell response
[12]. Both patterns are characterized by a spectrum of diﬀer-
entiation of the lymphoid cells with numerous small mature
lymphocytes in the background resulting in a polymorphic
impression at low power assessment (Figure 3(a)). In fol-
licular hyperplasia, LHAs of variable size with conspicuous
TBMs are often evident at low power, and a mixture of
centrocytes, centroblasts, and plasma cells is prominent
(Figure 4(a)). Immunoblasts are dominant in paracortical
hyperplasia, particularly viral lymphadenopathy. It is impor-
tant to note, however, that the two reaction patterns, follicu-
lar and paracortical hyperplasia, often present together. Also,
temporal changes in the cell composition occur until the
RLH resolves and are associated with concomitant cytologic
variations.
In most cases the etiology of the RLH remains unknown.
RLH most frequently aﬀects children and young adults.
Bacteria,viruses,chemicals,anddrugsarethemostcommon
inciting agents [12]. Considering patient age and cytomor-
phology, the diﬀerential diagnosis in most cases will include
Hodgkin lymphoma, T-cell lymphoma, and FL. Depending
on the degree of cytomorphologic change, ancillary testing
may need to be employed to exclude those mimics. After
cytologic diagnosis of RLH an attempt should be made to
establish the cause by appropriate history, serology, or other
investigations, but as mentioned above the etiology may
remain undetermined. If resolution of the lymphadenopathy
does not occur, excisional biopsy is warranted.
3.2. Marginal Zone B-Cell Lymphoma. Nodal MZL is a rare
neoplasm (1.5–1.8% of all lymphoid neoplasms [20]) which,
similar to RLH, presents with a distinctly polymorphic
cytologic pattern [21, 22]. By deﬁnition, nodal MZL presents
without evidence of extranodal or splenic disease. However,
the similarly rare splenic MZL and the more common extra-
nodal MZL of mucosa-associated lymphoid tissue (MALT)
may resemble nodal MZL in cytomorphology. LHAs may
be present, and only careful examination at higher power
may suggest the presence of monotonous neoplastic cells
within a background resembling nonspeciﬁc RLH. This may
be particularly problematic in partially involved nodes. In
contrast, in cases with follicular colonization, the smear may6 Pathology Research International
(a) (b) (c)
(d) (e) (f)
Figure 4: Smears produced from lymph node ﬁne-needle samples and examined at high power. High power assessment shows the
diﬀerences in cell composition between reactive lymphoid hyperplasia (a) and the cytological features of the neoplastic cells in marginal
zone lymphoma (b), follicular lymphoma (c), mantle cell lymphoma (d), chronic lymphocytic leukemia/small lymphocytic lymphoma (e),
and lymphoplasmacytic lymphoma (f). Follicular dendritic cells (black arrowheads), tingible body macrophages (black arrow) and mitoses
(white arrows) are present within a lymphohistiocytic aggregate seen in reactive lymphoid hyperplasia. Monocytoid B-cells (red arrow)
and plasmacytoid cells (white arrowheads) are often found in marginal zone lymphoma. Follicular dendritic cells are a prominent feature
of follicle center fragments present in samples of follicular lymphoma. These follicle center fragments do not show the other constituents
seen in the lymphohistiocytic aggregates of a reactive lymph node. Mitoses are also a frequent ﬁnding in mantle cell lymphoma, but are
not commonly seen in the other types of B-cell non-Hodgkin lymphoma illustrated here. Prolymphocytes (red arrowheads) are often
found in areas of vague nodularity present in smears of chronic lymphocytic leukemia/small lymphocytic lymphoma and identiﬁed by a
nucleolus which has a tinctorial quality similar to the cytoplasm of the cell. Plasmacytoid cells and mast cells (f: left lower image quadrant)
are constituents seen in lymphoplasmacytic lymphoma. (d: Diﬀ-Quik, all other: May-Gr¨ unwald-Giemsa; 63x).
contain numerous FCFs. Rare cases show a monotonous
intermediate-size cell pattern at low power assessment. The
neoplastic cells may be exclusively monocytoid, but more
typically are cytologically polymorphic with monocytoid
cells occurring alongside small lymphocyte- and centrocyte-
like cells [12] as well as with elements showing plasma cell
diﬀerentiation [20](Figures3(b)and4(b)).Thecytomorph-
ology of such samples, therefore, leads frequently to a broad
diﬀerential diagnosis including RLH as well as the spectrum
of lymphomas with small and intermediate-sized cells [23].
Finally, an important potential pitfall is peripheral T-cell
lymphoma which can mimic MZL morphologically [24].
MZL usually aﬀects the middle-aged and elderly, al-
thoughitmayoccurinchildren.Clinicalhistoryisimportant
with regard to multiple sites of involvement including intra-
abdominal lymphadenopathy and presence of constitutional
symptoms. Consideration should be given to the possibility
of nodal dissemination of extranodal MZL which occurs in
approximately one third of the cases [20]. The clinical course
is indolent, but transformation to a large B-cell lymphoma
may occur. Ancillary studies are particularly important in
making the diagnosis of MZL, but cases in which the reactive
cells obscure the neoplastic B-cell population even by immu-
nophenotyping may occur [25]. A further complication is
the well-documented occurrence of small clonal, but non-
neoplastic, B-cell populations in some of the chronic
inﬂammatory conditions, such as Sj¨ ogren’s syndrome, which
may be associated with extranodal marginal zone (MALT)
lymphoma.
3.3. Follicular Lymphoma. FL grade 1-2 is characterized by
a monotonous to somewhat dimorphic pattern, respectively.
FL grade 3A or 3B is characterized by a dominant population
of large cells resembling centroblasts and is, therefore, not
discussedhere.Thedimorphicpatternmayinitiallycausethe
false impression of a polymorphic cell composition at low
power. Regardless of grade, smears often give the low-power
impression of a nodular pattern which can be an importantPathology Research International 7
clue to the diagnosis (Figure 3(c)). At higher power, the
nodulescorrespondtonumerousFCFspopulatedbysmallto
intermediate-sized centrocytic cells with cleaved nuclei and
clumped chromatin (Figure 4(c)) .C e l l sw i t hd e e p l yc l e a v e d ,
apparently bilobed nuclei can be conspicuous [26]. Larger
centroblasts characterized by noncleaved nuclei, less dense
chromatin, and a narrow rim of dense cytoplasm are rare
in grade 1 FL, but occur with increasing frequency in grade
2 where both cell populations may be present in equal
numbers. Rarely, LHAs with TBMs may occur which should
not distract from the overall impression. LHAs and mitotic
activity are both uncommon, and the presence of either
shouldraisesuspicionforareactiveprocesswhichthenneeds
to be distinguished from partial lymph node involvement by
lymphoma. Of note, a rare signet-ring variant of FL exists
and is due to immunoglobulin stored within the cytoplasm
of the neoplastic cells. A diagnostic challenge can be posed
by diﬀuse FL which is rare and characterized by a lack of fol-
licular architecture in which case FCFs would be absent. The
diﬀerential diagnosis in this situation would include insuﬃ-
cient sampling of a FL displaying a focal diﬀuse component.
FL accounts for approximately 20% of all lymphomas,
and aﬀects adults and elderly individuals. FL occurring
before the age of 20 years is rare. Characteristically there is
often widespread nodal involvement at diagnosis. Histologic
grading of FL is based on the number of centroblasts per
high-power ﬁeld (HPF, 0.159mm2) counted in ten HPFs
within diﬀerent representative follicles [20]. Similar grading
can be performed on cytological preparations but is not
universally accepted [27, 28]. The vast majority of FLs are
grade 1 or 2. As distinction between these two is poorly
reproducible and not clinically important, the diagnostic
terminology usually reported is “follicular lymphoma, grade
1-2/3.” Although an indolent lymphoma, transformation to
diﬀuse large B-cell lymphoma (DLBCL) is more frequent
than with other low-grade lymphomas [12]a n da r e a so f
DLBCLarepresentinasubstantialproportionofgrade3FLs.
Fine-needle sampling plays an important role in the initial
assessment of FL since it allows sampling of multiple sites of
involvement so that the optimal site for excisional biopsy (if
required) can be determined. Similarly, in a case of suspected
transformation multiple ﬁne-needle samples improve the
chances of ﬁnding and documenting progression.
3.4. Mantle Cell Lymphoma. MCL is characterized, in con-
trast to the lymphomas considered previously, by a distinctly
monomorphiccellcomposition[29,30].Histologicallythree
patterns of MCL occur: diﬀuse, vaguely nodular, and mantle
zone pattern, the latter with preservation of preexisting
follicles. Accordingly, smears may be diﬀuse, show poorly
formed FCFs, or contain intact LHAs. The mantle zone
pattern, however, is rarely seen in cytologic material. Most
commonly, smears consist of a highly monotonous popula-
tion of lymphoid cells interrupted only by small round lym-
phocytes and occasional histiocytes [12]( Figure 3(d)). At
higher magniﬁcation, the cells have subtly irregular nuclear
contours reminiscent of centrocytes, dispersed to clumped
chromatin, mostly inconspicuous nucleoli, and moderate
amounts of cytoplasm. Mitotic ﬁgures may be observed, and
this feature can be used together with monomorphism and
nuclear contour irregularities in diﬀerentiating MCL from
other lymphomas [31]( Figure 4(d)). Diagnostic challenges
may be posed by any of the variants of MCL. Marginal zone-
like MCL and small cell MCL may be confused with MZL
or small lymphocytic lymphoma, respectively. The blastoid
and pleomorphic variant both display a more aggressive
clinical behavior and may enter the diﬀerential diagnosis in
cases sampled at relapse which can show increased nuclear
size, pleomorphism and mitotic activity [20]. The latter two
variants, again, can be confused with DLBCL.
MCL comprises 3–10% of lymphomas and predom-
inantly occurs in middle-aged to older males. Lym-
phadenopathy, hepatosplenomegaly, bone marrow, and
peripheral blood involvement are frequent. The median
survival is 3–5 years and the majority of patients cannot be
cured [20]. Grading of MCL is not performed. However, the
estimation of the proliferative fraction either by counting
mitotic ﬁguresorKi67 staining hasshownprognostic impact
[32]. Given the diﬀerent prognosis of MCL, ancillary testing
to discriminate the above-mentioned variants of MCL from
their less aggressive counterparts is crucial.
3.5. Small Lymphocytic Lymphoma/Chronic Lymphocytic
Leukemia. SLL/CLL is characterized by a monomorphic cel-
lular aspirate often without conspicuous nodularity or pres-
ence of aggregates. Thicker areas of a smear occasionally
show poorly deﬁned aggregates of cells that may corre-
spond to the proliferation centers associated with SLL/CLL
(Figures 3(e) and 5(a)). In Romanowsky-stained smears
these are appreciated as darker zones at low power, whereas
in H&E-stained histologic sections proliferation centers
appear as pale zones. Proliferation centers diﬀer from FCFs
inthattheydonotcontainfolliculardendriticcells.Athigher
magniﬁcation, small lymphoid cells with smooth-contoured
nuclei and minimal cytoplasm predominate (Figure 4(e)).
The chromatin frequently has a peculiar coarsely clumped
appearance best appreciated on Papanicolaou-stained slides
which led to the original designation as “cellules grumel´ ees”
[33, 34]( Figure 5(b)) ,at e r mw h i c hr e f e r st oc l o t t e dm i l k
or cheese curd. “Soccer balls” might be a better modern
appellation. Most cases have interspersed intermediate-
sized prolymphocytes with dispersed chromatin and obvious
nucleolus as well as paraimmunoblasts with broader, pale
cytoplasm, vesicular chromatin, and large central nucleolus
(Figures 4(e) and 5(b)). Both cell types are most often seen
in those ill-deﬁned aggregates corresponding to the prolif-
eration centers, and their presence provides a clue towards
the diagnosis. A common artifact in smears from patients
with CLL/SLL is the presence of smudge cells, also referred
to as basket cells or shadow cells of Gumprecht, which are
lymphoid cells stripped of their cytoplasm with the nuclear
material dispersed on the slide. This artifact, however, is not
speciﬁc to CLL/SLL. In samples with more than a few cells
with plasmacytoid features, lymphoplasmacytic lymphoma
(LPL) needs to be considered in the diﬀerential diagnosis
to CLL/SLL. Another important diﬀerential diagnosis is the
benign, minimal enlarged lymph node with a high propor-
tion of small lymphocytes and few secondary follicles which,8 Pathology Research International
(a) (b)
Figure 5:Fineneedlesamplesofchroniclymphocyticleukemia/smalllymphocyticlymphomaexaminedafterPapanicolaoustain.Severalill-
deﬁnedcellularaggregates(circle)arevisibleatlowpowerinspectiongivingtheimpressionofvaguenodularity(a).High-powerexamination
reveals the peculiar chromatin distribution and presence of numerous prolymphocytes (red arrowheads) within this area of increased cell
density (b). Note the coarse distribution of the chromatin and tinctorial quality of the nucleoli in the prolymphocytes in this stain. ((a) and
(b): Papanicolaou; (a): 10x, (b): 63x).
at ﬁrst glance, may cause a similarly monotonous impression
as CLL/SLL [35].
CLL/SLL is, in general, an indolent disease and occurs at
a mean age of 65 years. It is the most common lymphopro-
liferative disorder of adults in Western countries and shows
a slight male preponderance. The disease is rarely seen in
individuals of Asian descent. Fine-needle sampling is often
done to exclude Richter’s transformation to DLBCL which
occurs in 2–8%. Transformation to Hodgkin lymphoma
occurs in less than 1% of the patients. Immunoglobulin
gene mutation status and speciﬁc cytogenetic abnormalities
correlate with disease prognosis [20], and can be examined
using cytologic material.
3.6. Lymphoplasmacytic Lymphoma. Fine-needle specimens
from patients with LPL show a monomorphic, rarely more
polymorphic cell composition without a signiﬁcant number
ofcellaggregates.Thehinttothediagnosisisanadmixtureof
small lymphocytes and plasmacytoid cells (Figures 3(f) and
4(f)). Mature plasma cells may be present, but if dominant,
plasmacytoma should be considered in the diﬀerential
diagnosis. Intranuclear Dutcher bodies and intracytoplasmic
Russell bodies may be seen in the neoplastic cells, and
occasional multinucleated cells can be present. Mast cells
are often seen and are diagnostically helpful when frequent,
but they may also occur in other B-cell lymphomas with
small-/intermediate-sized cells [22]. In contrast to CLL/SLL,
prolymphocytes and paraimmunoblasts are absent which is
useful in excluding this diﬀerential diagnosis. Importantly,
LPL may be indistinguishable from MZL both histologically
or cytologically in which case ancillary testing and correla-
tion with clinical presentation are indispensable.
LPL is a rare lymphoma and most frequently occurs in
elderly patients with slight male predominance. The disease
is often associated with a paraprotein of IgM type, but this is
not required for diagnosis. Bone marrow involvement and
IgM monoclonal gammopathy are the diagnostic features
of Waldenstr¨ om macroglobulinemia found in a signiﬁcant
subset of patients with LPL. Autoimmune phenomena,
hyperviscosity, cryoglobulinemia, coagulopathies, and/or
neuropathy characterize the clinical course in a signiﬁcant
proportion of these patients. The lymphoma is typically
indolent, but transformationto DLBCL and, rarely, Hodgkin
lymphoma occurs in a small number of cases [20].
4.The Role of AncillaryTesting in
Small B-CellNon-Hodgkin Lymphoma
Due to the morphologic overlap between diﬀerent B-cell
NHLs with small-/intermediate-sized cells as well as with
RLH, ancillary testing plays a central role in their workup
[34, 36]. This is true regardless of the method with which
the specimen was obtained: excisional biopsy or ﬁne-needle
sample.Althoughsmearscanbeusedforimmunocytochem-
istry, it is much more practical to use cell suspensions which
can be submitted directly for ﬂow- or slide-based cytometry,
orforfurtherprocessingascytospinsorcellblocks[37].Each
ofthesemethodshasadvantagesanddisadvantages,andtheir
use is guided by the particular clinical circumstance and,
importantly, by the cytomorphology of the sample which
is the basis for a tentative diagnosis. Because material for
ancillary testing may be limited, the initial morphological
assessment becomes a crucial step and determines if a
particular investigative pathway will ultimately lead to the
correct diagnosis. Flow cytometry has become indispensable
in the diagnosis and classiﬁcation of B-cell NHLs with
small-/intermediate-sized cells [38, 39]. Some institutions
have developed expertise in slide-based cytometry which
can be used with specimens of very low cellularity and
yields immunophenotyping resultssimilar to ﬂow cytometry
[14, 40, 41]. However, ﬂow cytometry protocols using ten
or more colors can be similarly informative with extremely
paucicellular specimens.
The selection of the antibodies, again, is guided by
cytomorphology,clinicalhistory,andtheamountofmaterial
available for testing. A stepwise approach may be employedPathology Research International 9
whichincludes,ataminimum,kappa,lambda,CD19,CD20,
CD3, CD5, CD10, and CD23 for the initial assessment.
Additional markers such as CD4, CD8, CD7, CD2, CD43,
and FMC7 may be included upfront or subsequently. A
kappa:lambda ratio exceeding a threshold between 4:1 to
6:1 or a lambda:kappa ratio exceeding 3:1 on ﬂow cytom-
etry are generally suﬃcient to prove light chain restriction,
that is, monoclonality [12, 42]. The exact thresholds depend
on the cut-oﬀ(s) set by the individual laboratory. However,
in most cases of NHL, these ratios will be clearly surpassed.
Flow- or slide-based cytometry are ideal for markers with
cell surface expression and invaluable for the assessment of
antigen coexpression. Also, some intracellular antigens such
as Bcl-2 can be assessed by ﬂow cytometry after cell perme-
abilization. In contrast, the nuclear expression of Cyclin D1
is best examined using standardized immunohistochemical
staining protocols on cell block sections. MIB-1 as an indica-
tor of the proliferative activity may aid in the classiﬁcation
of a B-cell lymphoma according to its expected biological
behavior and can be evaluated by immunocytochemistry
[43].
Since normal lymph nodes show a predominance of T-
cells, a large proportion of CD20-positive B-cells in a ﬁne-
needle sample will raise the suspicion of lymphoma. Expres-
sion of CD5 and CD23 is indicative of CLL/SLL, the presence
of Bcl-2 in a population of germinal center cells positive
for CD10 or Bcl-6 is seen in FL, and staining for Cyclin
D1 is diagnostic for MCL. LPL will usually lack CD5 and
CD23 and show expression of CD38 as well as presence of
cytoplasmic immunoglobulin which distinguishes this entity
fromCLL/SLL.Immunophenotypingbyﬂowcytometrymay
be the most informative test in cases of MZL where it can
reveal a population of B-cells with light chain restriction
which, by cytomorphology, may be obscured by a reactive
background [38]. Variations may occur with any of the
mentioned immunophenotypic markers as exempliﬁed by a
range of CD23 expression in CLL/SLL [44]. Consequently, a
high level of vigilance is required as well as interpretation of
the ﬂow cytometric data in the context of morphological and
clinical information. Limitations to the use of ﬂow cytome-
try, which occur particularly with lymphoid neoplasms that
have a rich background of benign cells such as in Hodgkin
lymphoma or that have particularly fragile cells such as in
some large cell lymphomas, are not usually encountered in
B-cell NHLs with small-/intermediate-sized cells.
Cytogenetic testing, most commonly FISH, can be used
to demonstrate genetic abnormalities which are either (a)
recurrent and diagnostic for a speciﬁc lymphoma type, (b)
occur at an increased frequency, thus supporting a tentative
diagnosis, or (c) confer prognostic information [45]. Tri-
somy of chromosome 12 is most commonly seen in CLL/SLL
where it occurs in approximately 25% of the cases [12].
Trisomy12andtoagreaterextentdeletionsonchromosomes
11, 17, and 6 are associated with a poorer prognosis in
CLL/SLL whereas an isolated deletion of 13q14.3 is a positive
prognostic marker. MCL is characterized in almost all cases
(>95%) by translocation t(11;14)(q13;q32) which involves
the genes IGH and CCND1. Although rare cases may have
an alternative translocation, the diagnosis of MCL should be
made with caution in cases that are t(11;14) negative [46].
Slightly less frequent is the translocation t(14;18)(q32;q21)
which is seen in approximately 80% of FLs and results in
rearrangement of IGH and BCL2. In contrast, translocation
t(11;18)(q21;q21) which aﬀects the API2 and MALT1 genes
is only present in MZL of the extranodal sites (MALT),
but not in nodal MZL. Trisomies of chromosome 3 and
18 are nonspeciﬁc, but may support the diagnosis of MZL
in the appropriate context. There are marked variations in
the rate with which these genetic alterations can be detected
depending on the anatomic site involved by lymphoma with
reported frequencies for t(11;18), trisomy 3, and trisomy18
ranging between 0–56%, 11–75%, and 0–25%, respectively
[20]. No speciﬁc cytogenetic abnormalities have so far been
found for LPL leaving cytomorphology and immunophe-
notyping as primary diagnostic tools. Molecular studies,
mostly PCR-based assays for clonality and translocation
detection with or without sequencing, are, at the present
time, rarely used in the diagnostic workup of B-cell NHLs
with small-/intermediate-sized cells. Their application will
depend on speciﬁc situations where an attempt to classify
a neoplasm with the aforementioned techniques has left
questions unanswered.
5. Summary
The current World Health Organization (WHO) classiﬁca-
tion of tumors of the hematopoietic and lymphoid tissues
emphasizes cellular morphology in addition to immunophe-
notypic and genotypic characteristics [20]. Since a ﬁne-
needle sample, if properly obtained and processed, provides
excellent material for both cytomorphologic assessment and
ancillarytesting,theacceptanceofcytologyasdiagnostictool
in lymphoma diagnosis has increased considerably. Much
progress has been made since the publication by Chhieng
et al. [9] who, like various other groups, emphasized the
diﬃculty inherent in the cytologic recognition of B-cell
NHLs, especially those with predominant small cell com-
ponent. They reported that these low-grade lymphomas
accounted for a signiﬁcant percentage of false-negative or
indeterminate cases. However, they also stated that the
diagnosis of malignant lymphoma could be made in 82% of
their cases with a signiﬁcant contribution occurring through
the use of immunophenotyping which led to a substantial
improvement in diagnostic accuracy. Remarkably, when they
compared the results of the histologic assessment based on
REAL with their cytologic diagnosis, there was agreement in
85% of the cases. In a similar vein, Wakely Jr [8]r e p o r t e da
sensitivityof>80%andspeciﬁcityof>90%inthemajorityof
studies focused on the cytologic diagnosis of NHL. However,
these results may reﬂect the best possible scenario which may
not be accomplished in each setting [3].
Although much progress has been made over the past
decade and despite the development of sophisticated meth-
ods for ancillary testing, there is still signiﬁcant skepticism
towards the role of cytology in this setting, and excisional
biopsy is frequently regarded as essential for an accurate
initial diagnosis and classiﬁcation of malignant lymphoma
[47]. Some of this skepticism is attributed to the overlap10 Pathology Research International
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in morphologic features between B-cell NHLs with small-
/intermediate-sized cells as well as with benign reactive
and inﬂammatory lymphadenopathies. In fact, the signif-
icant impediments to ﬁne-needle sampling as stand-alone
approach to NHL diagnosis were discussed in a recent com-
mentary which also stressed the need for interdisciplinary
collaboration, multiparametric testing and on-site specimen
adequacy assessment as requirements for optimal results
[3]. Undoubtedly there are situations where even a tentative
diagnosis can only be rendered with great diﬃculty. Such
cases, however, are not unique to cytological specimens, and
this morphologic ambiguity is part of the reason why ancil-
lary testing, in particular immunophenotyping studies, are
considered mandatory in the diagnosis of lymphoprolifer-
ative disorders. It is important to emphasize, though, that
ancillary studies are crucially guided by the initial cytologic
evaluation of the sample which also provides the framework
for the proper interpretation of the immunophenotypic and
molecular testing results.
Some of the cytologic features of the B-cell NHLs review-
ed here have been recognized for some time, whereas
others are less well known or have been applied somewhat
more variably depending on the training of the individual
cytopathologist. An example is the recognition of FCFs in
cases of FL initially reported by Suh et al. [48], and their
distinction from LHAs based on the presence of follicular
dendritic cells alone in the former versus TBMs, follicular
dendritic cells and activated cells in the latter. A stepwise
approach as summarized in Table 1, which includes a low
power assessment for cellularity, monomorphism, and pre-
dominant cell size with an astute examination for residual
architectural features, that is, cell aggregates, followed by a
detailed interrogation of the cytologic features at high power
will yield the largest amount of information on which a
tentative diagnosis can be built, and has the least potential
to cause diagnostic confusion.
Awareness of the diagnostic limitations and pitfalls is
of key importance in advancing the acceptance for a cyto-
logic diagnosis of lymphomas. Other sampling techniques
including excisional biopsy should be considered where the
cytologic diagnosis is equivocal or lymphadenopathy persists
without deﬁnitive cause. Situations in which other sampling
modalities may be given preference include, but are not
limited to, suspected T-cell lymphoma, Hodgkin lymphoma
andcompositelymphomas[49].Excisionalbiopsiesmayalso
be necessary to satisfy criteria for participation in a clinical
trial or for purposes of tissue banking for potential future
diagnostic and therapeutic developments. Finally, histologic
examination may also be necessary due to persistent contro-
versies such as those related to the grading of FL. On the
other hand, excisional biopsy in SLL/CLL is probably never
warranted, unless Richter’s transformation is suspected, and
it can be argued that in the case of the indolent, but currently
incurable, B-cell NHL with small-/intermediate-sized cells
under clinical observation alone, excisional biopsy is best
left for a point in the illness when therapeutic intervention
becomes necessary.
6. Conclusion
With the advent of sophisticated techniques for ancillary
testing and with the emphasis on cytomorphologic and
immunophenotypic characteristics for the classiﬁcation of
NHLs, there has been a resurgence in interest in cytologic
diagnosis of lymphoproliferative disorders. The cytomor-
phologic features of B-cell NHLs with small-/intermediate-
sized cells in many cases are suﬃciently characteristic to
permitatleastsomedegreeofdiﬀerentiation.Theassessment
of these features can be applied in a stepwise or algorithmic
fashion to discriminate between entities and to arrive at
aﬁ n a ld i ﬀerential diagnosis which can be resolved with
additional testing. Clinical data, immunophenotyping and
cytogenetics provide the context for cytomorphology, and
permit accurate diagnoses to be rendered even in this
challenging area. Hence, we conclude that the medical
community has come closer to realizing the full potential of
ﬁne-needle cytopathology.
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